Immunologic Significance of HLA Class I Genes in Measles Virus-specific IFN-gamma and IL-4 Cytokine Immune Responses

Overview

Journal Immunogenetics

Specialties Allergy & Immunology
Genetics

Date 2005 Dec 7

PMID 16331510

Citations 27

Authors

Inna G Ovsyannikova

Jenna E Ryan

Robert A Vierkant

V Shane Pankratz

Robert M Jacobson

Gregory A Poland

Affiliations

Soon will be listed here.

Abstract

The variability of immune responses modulated by human leukocyte antigen (HLA) genes and secreted cytokines is a significant factor in the development of a protective effect of measles vaccine. We studied the association between type 1 helper T cells (Th1)- and Th2-like cytokine immune responses and HLA class I alleles among 339 schoolchildren who previously received two doses of the measles vaccine. Median values for measles-specific interferon gamma (IFN-gamma) and interleukin-4 (IL-4) cytokines were 40.7 pg/ml [interquartile range (IQR) 8.1-176.7] and 9.7 pg/ml (IQR 2.8-24.3), respectively. Class I HLA-A (*0101 and *3101) and HLA-Cw (*0303 and *0501) alleles were significantly associated with measles-virus-induced IFN-gamma secretion. HLA-A*3101 and Cw*0303 were associated with a higher median IFN-gamma response, while A*0101 and Cw*0501 were associated with lower measles-specific IFN-gamma response. We found limited associations between HLA class I gene polymorphisms and Th2-like (IL-4) immune responses after measles vaccination, indicating that HLA class I molecules may have a limited effect on measles-vaccine-induced IL-4 secretion. Understanding the genetic factors that influence variations in cytokine secretion following measles vaccination will provide insight into the factors that influence both cell-mediated and humoral immunity to measles.

Citing Articles

Prediction of Specific Antibody- and Cell-Mediated Responses Using Baseline Immune Status Parameters of Individuals Received Measles-Mumps-Rubella Vaccine.

Toptygina A, Grebennikov D, Bocharov G Viruses. 2023; 15(2).

PMID: 36851738 PMC: 9960117. DOI: 10.3390/v15020524.

Vaccinomics: A scoping review.

Dudley M, Gerber J, Budigan Ni H, Blunt M, Holroyd T, Carleton B Vaccine. 2023; 41(14):2357-2367.

PMID: 36803903 PMC: 10065969. DOI: 10.1016/j.vaccine.2023.02.009.

Mumps virus-specific immune response outcomes and sex-based differences in a cohort of healthy adolescents.

Riggenbach M, Haralambieva I, Ovsyannikova I, Schaid D, Poland G, Kennedy R Clin Immunol. 2021; 234:108912.

PMID: 34968746 PMC: 8760162. DOI: 10.1016/j.clim.2021.108912.

Why do Individuals Differ in Viral Susceptibility? A Story Told by Model Organisms.

van Sluijs L, Pijlman G, Kammenga J Viruses. 2017; 9(10).

PMID: 28973976 PMC: 5691635. DOI: 10.3390/v9100284.

The effectiveness of measles-mumps-rubella (MMR) vaccination in the prevention of pediatric hospitalizations for targeted and untargeted infections: A retrospective cohort study.

La Torre G, Saulle R, Unim B, Meggiolaro A, Barbato A, Mannocci A Hum Vaccin Immunother. 2017; 13(8):1879-1883.

PMID: 28604255 PMC: 5557224. DOI: 10.1080/21645515.2017.1330733.

References

van Els C, Herberts C, van der Heeft E, Poelen M, Van der Kooi A, Hoogerhout P . A single naturally processed measles virus peptide fully dominates the HLA-A*0201-associated peptide display and is mutated at its anchor position in persistent viral strains. Eur J Immunol. 2000; 30(4):1172-81. DOI: 10.1002/(SICI)1521-4141(200004)30:4<1172::AID-IMMU1172>3.0.CO;2-J. View

Ward B, Boulianne N, Ratnam S, Guiot M, Couillard M, De Serres G . Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination. J Infect Dis. 1995; 172(6):1591-5. DOI: 10.1093/infdis/172.6.1591. View

Robinson J, Delvig A . Diversity in MHC class II antigen presentation. Immunology. 2002; 105(3):252-62. PMC: 1782669. DOI: 10.1046/j.0019-2805.2001.01358.x. View

Poland G . Variability in immune response to pathogens: using measles vaccine to probe immunogenetic determinants of response. Am J Hum Genet. 1998; 62(2):215-20. PMC: 1376909. DOI: 10.1086/301736. View

Nabel G, Nabel E, Yang Z, Fox B, Plautz G, Gao X . Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci U S A. 1993; 90(23):11307-11. PMC: 47971. DOI: 10.1073/pnas.90.23.11307. View

Mongkolsapaya J, Jaye A, Callan M, Magnusen A, McMichael A, Whittle H . Antigen-specific expansion of cytotoxic T lymphocytes in acute measles virus infection. J Virol. 1998; 73(1):67-71. PMC: 103809. DOI: 10.1128/JVI.73.1.67-71.1999. View

Dhiman N, Ovsyannikova I, Howe R, Ryan J, Jacobson R, Poland G . Interleukin-4 induced by measles virus and measles-derived peptides as measured by IL-4 receptor-blocking ELISA. J Immunol Methods. 2004; 287(1-2):217-25. DOI: 10.1016/j.jim.2004.02.002. View

van Binnendijk R, van Baalen C, Poelen M, de Vries P, Boes J, Cerundolo V . Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition. J Exp Med. 1992; 176(1):119-28. PMC: 2119300. DOI: 10.1084/jem.176.1.119. View

Cutts F, Markowitz L . Successes and failures in measles control. J Infect Dis. 1994; 170 Suppl 1:S32-41. DOI: 10.1093/infdis/170.supplement_1.s32. View

10.

Sette A, Sidney J . HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. Curr Opin Immunol. 1998; 10(4):478-82. DOI: 10.1016/s0952-7915(98)80124-6. View

11.

Ward B, Griffin D . Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clin Immunol Immunopathol. 1993; 67(2):171-7. DOI: 10.1006/clin.1993.1061. View

12.

Arnot D, Lillie J, Auffray C, Kappes D, Strominger J . Inter-locus and intra-allelic polymorphisms of HLA class I antigen gene mRNA. Immunogenetics. 1984; 20(3):237-52. DOI: 10.1007/BF00364206. View

13.

Wang C, Tang J, Song W, Lobashevsky E, Wilson C, Kaslow R . HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology. 2004; 39(4):978-88. DOI: 10.1002/hep.20142. View

14.

Ovsyannikova I, Jacobson R, Ryan J, Vierkant R, Pankratz V, Jacobsen S . HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine. Immunogenetics. 2005; 56(11):798-807. DOI: 10.1007/s00251-004-0756-0. View

15.

Ward B, Johnson R, Vaisberg A, Jauregui E, Griffin D . Cytokine production in vitro and the lymphoproliferative defect of natural measles virus infection. Clin Immunol Immunopathol. 1991; 61(2 Pt 1):236-48. DOI: 10.1016/s0090-1229(05)80027-3. View

16.

Poland G, Jacobson R, Schaid D, Moore S, Jacobsen S . The association between HLA class I alleles and measles vaccine-induced antibody response: evidence of a significant association. Vaccine. 1998; 16(19):1869-71. DOI: 10.1016/s0264-410x(98)00017-6. View

17.

Ovsyannikova I, Reid K, Jacobson R, Oberg A, Klee G, Poland G . Cytokine production patterns and antibody response to measles vaccine. Vaccine. 2003; 21(25-26):3946-53. DOI: 10.1016/s0264-410x(03)00272-x. View

18.

Ottenhoff T, Elferink D, Hermans J, de Vries R . HLA class II restriction repertoire of antigen-specific T cells. I. The main restriction determinants for antigen presentation are associated with HLA-D/DR and not with DP and DQ. Hum Immunol. 1985; 13(2):105-16. DOI: 10.1016/0198-8859(85)90017-5. View

19.

PABST H, Spady D, Carson M, Stelfox H, Beeler J, Krezolek M . Kinetics of immunologic responses after primary MMR vaccination. Vaccine. 1997; 15(1):10-4. DOI: 10.1016/s0264-410x(96)00124-7. View

20.

Hollsberg P . Contribution of HLA class I allele expression to CD8+ T-cell responses against Epstein-Barr virus. Scand J Immunol. 2002; 55(2):189-95. DOI: 10.1046/j.0300-9475.2001.01043.x. View